Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls

[1]  R. Perlis,et al.  Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls , 2019, Translational Psychiatry.

[2]  Jonathan P. Beauchamp,et al.  Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals , 2018, Nature Genetics.

[3]  S. Linnarsson,et al.  Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways , 2018, Nature Genetics.

[4]  Nicholette D. Palmer,et al.  Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries , 2018, PloS one.

[5]  Jun Li,et al.  Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. , 2018, The lancet. Psychiatry.

[6]  C. Hultman,et al.  Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls , 2017, Psychiatry Research.

[7]  D. Posthuma,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[8]  R. McIntyre,et al.  Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications , 2017, Brain sciences.

[9]  M. O’Donovan,et al.  Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia , 2017, Nature Genetics.

[10]  M. Kanai,et al.  Genome-wide association study identifies 112 new loci for body mass index in the Japanese population , 2017, Nature Genetics.

[11]  Z. Fišar,et al.  Biological hypotheses and biomarkers of bipolar disorder , 2017, Psychiatry and clinical neurosciences.

[12]  P. Qiu,et al.  A new bioinformatic insight into the associated proteins in psychiatric disorders , 2016, SpringerPlus.

[13]  H. Whalley,et al.  DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorder , 2016, Clinical Epigenetics.

[14]  J. Smoller,et al.  A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder , 2015, Molecular Psychiatry.

[15]  Ather Muneer.  Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers , 2015, Psychiatry investigation.

[16]  N. Craddock,et al.  Genome-wide association study identi fi es SESTD1 as a novel risk gene for lithium-responsive bipolar disorder , 2023 .

[17]  Tanya M. Teslovich,et al.  The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study , 2015, PLoS Genetics.

[18]  K. Blennow,et al.  Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. , 2015, Journal of psychiatry & neuroscience : JPN.

[19]  K. Blennow,et al.  Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls , 2015, PloS one.

[20]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[21]  P. Lichtenstein,et al.  Bipolar disorder and its relation to major psychiatric disorders: a family‐based study in the Swedish population , 2015, Bipolar disorders.

[22]  K. Blennow,et al.  Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment , 2015, Brain, Behavior, and Immunity.

[23]  Perry G. Ridge,et al.  Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation , 2014, PLoS genetics.

[24]  Daniel L. Koller,et al.  Identification of pathways for bipolar disorder: a meta-analysis. , 2014, JAMA psychiatry.

[25]  Don L. Armstrong,et al.  GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region , 2014, Genes and Immunity.

[26]  Janice M. Fullerton,et al.  Genome-wide association study reveals two new risk loci for bipolar disorder , 2014, Nature Communications.

[27]  S. Bojesen,et al.  Genetic variants in CHI3L1 influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population , 2013, Journal of Medical Genetics.

[28]  K. Blennow,et al.  Altered Concentrations of Amyloid Precursor Protein Metabolites in the Cerebrospinal Fluid of Patients with Bipolar Disorder , 2013, Neuropsychopharmacology.

[29]  M. Landén,et al.  Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder , 2012, Bipolar disorders.

[30]  K. Blennow,et al.  Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study , 2012, Journal of Neuroinflammation.

[31]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[32]  R. Handsaker,et al.  Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder , 2012, Molecular Psychiatry.

[33]  Paul Scheet,et al.  A Genome-Wide Association Scan on the Levels of Markers of Inflammation in Sardinians Reveals Associations That Underpin Its Complex Regulation , 2012, PLoS genetics.

[34]  P. Elliott,et al.  Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.

[35]  M. Rietschel,et al.  Genome-Wide Association Studies of Alcohol Dependence and Substance Use Disorders , 2011, Current psychiatry reports.

[36]  S. Djurovic,et al.  A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. , 2010, Journal of affective disorders.

[37]  Ming D. Li,et al.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.

[38]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[39]  K. Blennow,et al.  Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD , 2009, Journal of Neural Transmission.

[40]  M. Thase,et al.  A history of childhood attention‐deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD , 2009, Acta psychiatrica Scandinavica.

[41]  S. Bojesen,et al.  Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  F J McMahon,et al.  Convergent functional genomics of genome‐wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[43]  S. Gabriel,et al.  Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.

[44]  M. Daly,et al.  Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.

[45]  S. Cichon,et al.  A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder , 2008, Molecular Psychiatry.

[46]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[47]  Theo Stijnen,et al.  Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes , 2007, Diabetes.

[48]  C Henry,et al.  Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14 , 2006, Molecular Psychiatry.

[49]  B. Maier,et al.  Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. , 2005, Journal of neurotrauma.

[50]  J. Kaprio,et al.  High concordance of bipolar I disorder in a nationwide sample of twins. , 2004, The American journal of psychiatry.

[51]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[52]  P. Ridker,et al.  C-reactive protein and the risk of developing hypertension. , 2003, JAMA.

[53]  P. Sham,et al.  The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. , 2003, Archives of general psychiatry.

[54]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[55]  L. Judd,et al.  A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. , 2003, Archives of general psychiatry.

[56]  John A. Rice,et al.  The long-term natural history of the weekly symptomatic status of bipolar I disorder. , 2002, Archives of general psychiatry.

[57]  M. Neale,et al.  Genetic and Environmental Factors in Relative Body Weight and Human Adiposity , 1997, Behavior genetics.

[58]  L Peltonen,et al.  Replication of GWAS of bipolar disorder: association of SNPs near CDH7 with bipolar disorder and visual processing , 2010, Molecular Psychiatry.